Judge: Frank M. Tavelman, Case: 21STCV24782, Date: 2023-04-21 Tentative Ruling
Case Number: 21STCV24782 Hearing Date: April 21, 2023 Dept: A
LOS
ANGELES SUPERIOR COURT
NORTH
CENTRAL DISTRICT - BURBANK
DEPARTMENT
A
TENTATIVE
RULING
APRIL 21,
2023
MOTION FOR
SUMMARY JUDGMENT
Los Angeles Superior Court
Case # 21STCV24782
|
MP: |
Nadia J. Fakoory M.D. (Defendant) |
|
RP: |
Cathy Schlesinger and David Gaines
(“Plaintiffs”) |
ALLEGATIONS:
Cathy
Schlesinger (“Schlesinger”) and David Gaines (“Gaines”) (collectively
“Plaintiffs”) allege that, on April 8, 2020, Schlesinger was a patient of Nadia
Jean Fakoory, M.D. (“Fakoory”) in the emergency department of Providence St.
Joseph Medical Center (hereinafter “ED”). On July 6, 2021, Plaintiffs filed a
complaint against Fakoory, Providence Health System-Southern California dba
Providence St. Joseph Medical Center erroneously sued as Providence St. Joseph
Med Center (“Providence”), Woody Herman Jackson, M.D. (“Jackson”), Robin
Solymanijam, M.D. (“Solymanijam”), Karo K Arzoo, M.D. (“Arzoo”), Mariam
Torossian (“Torossian”), and Grace I. Wong, M.D. (“Wong”) (collectively,
“Defendants”).
On
December 21, 2021, Plaintiffs filed a first amended complaint (“FAC”) against
Defendants alleging five causes of action for (1) medical negligence [by
Schlesinger against Defendants], (2) lack of informed consent [by Schlesinger
against Fakoory], (3) lack of informed consent [by Schlesinger against Jackson
and Solymanijam], (4) lack of informed consent [by Schlesinger against Arzoo],
and (5) loss of consortium [by Gaines against Defendants].
Accordingly,
three causes of action are asserted against Fakoory. Plaintiffs allege Fakoory’s
conduct fell below the standard of care during treatment of Schlesinger.
Specifically, Plaintiffs allege Fakoory negligently ordered the administration
of the vasopressor drugs Levophed and Dopamine (“vasopressors”) which
subsequently caused a paroxysmal atrial fibrillation. Plaintiffs further allege
Fakoory failed to provide adequate information prior to the administration of
the vasopressors, preventing Schlesinger from objecting to the treatment.
HISTORY:
Fakoory
moves for summary judgment of the FAC. Fakoory argues there is no triable issue
of material fact as to the first cause of action for Medical Negligence and second
cause of action for Lack of Informed Consent. Fakoory argues that the Schlesinger
claims against her cannot be sustained, and therefore Gaines’ derivative claim
for loss of consortium likewise fails.
Plaintiffs
oppose the motion and Fakoory replies.
EVIDENTIARY OBJECTIONS:
Fakoory’s evidentiary objections Nos.
1-7 to the declaration of Gregory
Wu, M.D. are OVERRULED.
ANALYSIS:
I.
LEGAL
STANDARD
A party
may move for summary judgment when the action has no merit or that there is no
defense to the action or proceeding. (C.C.P. § 437c(a).) To prevail on a motion
for summary judgment, the evidence submitted must show there is no triable
issue as to any material fact and that the moving party is entitled to judgment
as a matter of law. (C.C.P. § 437c(c).) In other words, the opposing party
cannot present contrary admissible evidence to raise a triable factual dispute.
“A
defendant or cross-defendant has met his or her burden of showing that a cause
of action has no merit if the party has shown that one or more elements of the
cause of action, even if not separately pleaded, cannot be established, or that
there is a complete defense to the cause of action. Once the defendant or
cross-defendant has met that burden, the burden shifts to the plaintiff or
cross-complainant to show that a triable issue of one or more material facts
exists as to the cause of action or a defense thereto. The plaintiff or cross-complainant
shall not rely upon the allegations or denials of its pleadings to show that a
triable issue of material fact exists but, instead, shall set forth the
specific facts showing that a triable issue of material fact exists as to the
cause of action or a defense thereto.” (C.C.P. § 437c(p)(2).)
When
ruling on a summary judgment motion, the trial court must consider all
inferences from the evidence, even those contradicted by the moving party’s
evidence. The motion cannot succeed unless the evidence leaves no room for
conflicting inferences as to material facts; the court has no power to weigh
one inference against another or against other evidence. (Murillo v. Rite
Stuff Food Inc. (1998) 65 Cal. App. 4th 833, 841.) In determining whether
the facts give
rise to a triable issue of
material fact, "the facts alleged in the evidence of the party opposing
summary judgment and the reasonable inferences there from must be accepted as
true.” (Jackson v. County of Los Angeles (1997) 60 Cal. App. 4th 171,
179.)
With a
summary judgment motion, a three-step analysis is required of the trial court.
(AARTS Productions, Inc. v. Crocker Nat’l Bank (1986) 179 Cal. App. 3d
1061, 1064–65.) First, the trial court must identify the issues framed by the
pleadings since it is these allegations to which the motion must respond by
establishing a complete defense or otherwise showing there is no factual basis
for relief on any theory reasonably contemplated by the opponent’s pleading. (Id.)
Secondly, the court must determine whether the moving party’s showing has
established facts which negate the opponent’s claim and justify a judgment in
movant’s favor. (Id.) When summary judgment motion prima facie justifies
a judgment, the third and final step is to determine whether the opposition
demonstrates the existence of a triable, material factual issue. (Id.)
When
considering the declarations of the parties’ experts, the Court liberally
construes the declaration for the plaintiff’s experts and resolves any doubts
as to the propriety of granting the motion in favor of plaintiff. (Powell v.
Kleinman (2007) 151 Cal.App.4th 112, 126.)
II.
MERITS
Medical
Negligence (First COA)
“The
elements of a cause of action for medical malpractice are: (1) a duty to use
such skill, prudence, and diligence as other members of the profession commonly
possess and exercise; (2) a breach of the duty; (3) a proximate causal
connection between the negligent conduct and the injury; and (4) resulting loss
or damage.” (Chakalis v. Elevator Solutions, Inc. (2012) 205 Cal.App.4th
1557, 1571.)
The
standard of care against which the acts of a physician are to be measured is a
matter peculiarly within the knowledge of experts; it presents the basic issue
in a malpractice action and can only be proved by their testimony. (Hanson
v. Grode (1999) 76 Cal.App.4th 601, as modified (Nov. 29,
1999). When a defendant moves for summary judgment and supports
his motion with expert declarations that his conduct fell within the community
standard of care, he is entitled to summary judgment unless the
plaintiff comes forward with conflicting expert evidence.’ (Citations.)” (Munro v. Regents of University of California (1989)
215 Cal.App.3d 977, 984–985.)
Fakoory
claims no material fact exists as to whether her behavior fell below the
standard of care. To satisfy her burden, Fakoory must produce evidence that her
treatment of Schlesinger did not fall below the standard of care. Fakoory
submits the declaration of George Baskevitch, M.D. (“Baskevitch”). Baskevitch states
Fakoory’s administration of IV fluids was within the standard of care.
(Baskevitch Decl. ¶ 5.) Baskevitch explains the standard of care for fluid
administration requires individual assessment of the patient to treat
sepsis/septic shock. (Id. ¶ 14.) Baskevitch states the actions Fakoory
took in assessing and administering vasopressors were within the standard of
care. (Baskevitch Decl. ¶ 18.)
The Court
finds Fakoory has satisfied her burden. Plaintiffs subsequently bear the burden to produce evidence of the
existence of a triable issue of material fact surrounding Fakoory’s
administration of vasopressors.
Plaintiffs
dispute Baskevitch’s claim that the administration of vasopressors was within
the standard of care. Baskevitch states:
“At 5:17 a.m., the plaintiff’s BP was
still critically low. Dr. Fakoory ordered a Dopamine infusion in conjunction
with the Levophed and IV fluid support, which was administered at 5:30 am. At
5:42 a.m. the plaintiff’s BP had improved to 97/51, which is consistent with
Sepsis Criteria Goals MAP [Mean Arterial Pressure] over 65 (66.3).”
(Baskevitch, Decl. ¶11.)
Baskevitch also states:
“Dr. Fakoory’s
initial order that in conjunction with IV fluids the plaintiff receive Levophed
3mcg at 3:58 a.m., and then subsequent titrations up incrementally to a maximum
of 30mcg at 5:15 a.m., was appropriate and met the standard of care. The
plaintiff’s BP remained critically low. Dr. Fakoory’s choice of Levophed and
then Dopamine was in keeping with standard of care recommendations.
Vasopressors are given to septic patients in order to help support a patient’s
low BP. An optimal systolic BP should be 90 or above. Low BP is associated with
organ hypoperfusion, which can lead to organ failure and death. Because of
this, it is imperative that a patient’s BP is raised through the use of
vasopressors.”
(Baskevitch Decl. ¶¶ 5, 8-10, 17-20, Exhibit C, Exhibit D.)
In opposition, Plaintiffs submit the declaration of Gregory Wu, M.D. (“Wu”). Wu
states “The target to measure the response with the mean arterial pressure
(MAP) =65 mmHg was being met when FAKOORY ordered dopamine infusion on 04/08/20
at 0520. (Wu Decl. ¶ 46.) Wu also states Fakoory violated the appropriate
standard of care when she ordered the dopamine. (Id.)
In
reply, Fakoory argues Wu’s statement is contradictory. Wu states the MAP
reading taken at 0517, minutes before Dr. Fakoory placed her order at 0520, was
64, which is not =65 mmHg. (Wu Decl. ¶¶ 28, 30.) Fakoory argues that, by Wu’s
own statement, the Plaintiff’s MAP target was not being met at the time Dr.
Fakoory placed her order for dopamine.
“[E]xpert opinions …
are worth no more than the reasons and factual data upon which they are based.”
(Griffith v. County of Los Angeles (1968) 267 Cal.App.2d 837, 847.) Both Baskevitch
and Wu base their opinions on Schlesinger’s medical record. Schlesinger’s
medical record is attached as Exhibit C to the Baskevitch declaration and
Exhibit 1 to the Wu declaration. Relevant to the disputed statements of fact is
the ED care timeline located at pages 656-695 of Schlesinger’s medical record.
Page 682 of this record confirms that 5:17 was the most
recent measurement of MAP before Fakoory ordered vasopressors be administered.
At 5:17, Kristine Adalmy, RN measured Schlesinger’s MAP to be 64 mmHg. (Schlesinger
Med. Rec. pg. 682.) At 5:19:04, Fakoory placed orders for dopamine 3,200 mcg/mL
in sodium chloride 0.9% 250 mL infusion (Id.) At 5:19:41, these orders
were discontinued by Divvjyot Singh, PharmD. (Id.) At 5:20:27, orders
were placed for dopamine in dextrose 1,600 mcg/mL infusion by Woody Herman
Jackson, M.D. (Id.) At 5:30 dopamine began to be administered. (Id. at
683.)
Schlesinger’s record
indicates her MAP
was measured twice between Fakoory’s ordering the dopamine at 5:19:04 and its
administration at 5:30. Schlesinger’s MAP
was measured to be 65 mmHg at 5:22. Schlesinger’s
MAP was measured again at 5:27, reading 68 mmHg. Both readings were at or above
the target MAP of =65 mmHg. Wu’s statement acknowledges both measurements. (Wu
Decl. ¶¶ 32-33.) The Court finds Wu’s statement, based upon his review of
Schlesinger’s medical record, is not contradictory.
The Court finds Wu’s statement presents a triable issue of
fact as to whether Fakoory was negligent in administering the dopamine. Fakoory
and Plaintiff have presented competing expert witness statements. Fakoory has
met her initial burden and Plaintiffs have met their burden in kind. As such,
the Court denies the motion for summary judgment.
Lack of Informed Consent (Second Cause of Action)
Considering the denial of
summary judgment, the Court does not address Fakoory’s arguments as to lack of
informed consent.
Loss of Consortium
(Fifth COA)
A claim for loss of
consortium contains four elements: (1) a valid and lawful marriage between
the plaintiff and the
person injured at the time of the injury, (2) a tortious injury to the
plaintiff's spouse, (3) loss of consortium suffered by the plaintiff, and (4)
the loss was proximately caused by the defendant's act. (LeFiell
Manufacturing Co. v. Superior Court (2012) 55 Cal.4th 275, 284-285.) “‘A
cause of action for loss of consortium is, by its nature,
dependent on the existence of a cause of action for tortious injury to a
spouse.’ (Citation).” (Id.)
Fakoory argues Gaines’
loss of consortium claim against her is derivative of Schlesinger’s
professional negligence action. (Mot. pg. 9.) Fakoory argues because the claims
of negligence and lack of informed consent fail, so too must Gaines’ loss of
consortium claim. As the Court denies summary judgment, it cannot be said
Gaines’ claim fails as matter of law.
III.
CONCLUSION
The Court
finds Fakoory has met her burden through the declaration of Baskevitch. The
Court finds Plaintiffs have met their burden through the declaration of Wu. As
such, Plaintiffs show a triable issue of fact as to whether Fakoory’s actions
fell below the standard of care. As such, the court DENIES the Motion for
Summary Judgment.
---
RULING:
In the
event the parties submit on this tentative ruling, or a party requests a signed
order or the court in its discretion elects to sign a formal order, the following
form will be either electronically signed or signed in hard copy and entered
into the court’s records.
ORDER
Nadia J. Fakoory M.D.’s
Motion for Summary Judgment came on regularly for
hearing on March 28, 2023 AND WAS CONTINUED ON THE COURT’S MOTION TO APRIL 21,
2023, with appearances/submissions as noted in the minute order for said
hearing, and the court, being fully advised in the premises, did then and there
rule as follows:
THE MOTION FOR SUMMARY JUDGMENT IS DENIED.
PLAINTIFF TO GIVE NOTICE.
IT IS SO
ORDERED.
DATE:
April 21, 2023 _______________________________
F.M. TAVELMAN, Judge
Superior Court of California
County of
Los Angeles